心脏衰竭中的性别差异:向前迈出了一步
Sachintha Wijesinghe1, Marie-Luise Dikou1, Ioannis Kasouridis2
1Department of Cardiology, Guy's and St Thomas' NHS Trust London, UK.
Interventional cardiology (London, England)
|June 16, 2025
概括
心力衰竭对男性和女性的影响不同,预计患病率和死亡率将增加. 本综述考察了整个心力衰竭频谱中的基于性别的差异.
科学领域:
- 心脏病学 心脏病学
- 基于性别的医学
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是一种具有重大个人和社会负担的危急疾病.
- 患者年龄的增加预测HF患病率和死亡率的快速上升.
- 现有的研究往往忽略了心力衰竭中关键的性别差异.
研究的目的:
- 在心力衰竭 (HF) 中全面审查和突出性别差异.
- 提供关于HF在女性和男性中如何表现和进展的洞察力.
- 为未来的研究和临床实践提供有关性别特异性HF管理的信息.
主要方法:
- 文献审查方法.
- 综合现有关于心力衰竭性别差异的研究.
- 对心力衰竭的全谱进行分析,从早期阶段到晚期的疾病.
主要成果:
- 在心力衰竭病因,表现和结果方面存在显著的基于性别的差异.
- 生物学 (例如,荷尔蒙) 和社会因素有助于这些差异.
- 当前的理解和治疗指南可能无法充分解决这些性别差异.
结论:
- 承认和理解性别差异对于有效的心力衰竭管理至关重要.
- 需要进一步的研究来阐明这些差异背后的机制.
- 根据性别定制治疗策略可能会改善患者的治疗结果并降低医疗保健成本.
相关概念视频
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure I: Introduction
79
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
79
Heart Failure III: Clinical Manifestations
60
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
60
Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
Heart Failure IV: Classification and Diagnostic Evaluation
43
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
43
Heart Failure Drugs: β-Blockers
446
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
446


